Albinism is a genetic condition that results in reduced or absent biosynthesis of one or multiple forms of melanin (eumelanin, pheomelanin, neuromelanin), all of which have a role in visual development.
1,2 As a result, aberrant visual development occurs at the level of the retina and visual cortical pathways. Approximately 1:17,000 people worldwide have albinism either in isolation or as part of a genetic syndrome, with greater prevalence (1:3000) in some regions (e.g., Puerto Rico, Fiji).
3 There are several distinct genotypes of albinism, with different inheritance patterns, including those with overall melanin deficiency, resulting in oculocutaneous albinism, as well specific melanin deficiencies, resulting in ocular-only albinism.
4 The following ocular findings are known to be associated with albinism, including iris transillumination,
1 hyperopic refractive error,
5–7 foveal hypoplasia, nasotemporal shift in retinal ganglion cell fibers secondary to a greater percentage of uncrossed fibers at the optic chiasm,
8 nystagmus,
9,10 and strabismus.
11,12 Misrouting of the optic nerves at the chiasm may vary in its extent in PwA,
13 resulting in abnormal visual field representation in the visual brain.
14 PwA often have visual deficits including reduced visual acuity,
6,12,15 an elevated subjective sense of glare/photosensitivity,
16 atypical color discrimination,
17 reduced contrast sensitivity,
10,18,19 reduced or absent stereoacuity,
7,9,20 and interocular suppression.
7 A retrospective review revealed that the PwA without nystagmus had improved stereoacuities compared to PwA with nystagmus and that individuals with stereopsis had better binocular visual acuities than those without stereopsis.
21 Another study reported increased internal noise in motion discrimination and motion coherence for simple unidirectional motions in the presence of nystagmus but no difference without nystagmus.
9 Quality of life and vision-specific quality of life are affected as a consequence.
22,23